With glaring inequities in the supply and distribution of vaccines, the Biden administration has backed a plan to waive intellectual property rights for Covid-19 vaccines and treatments. We speak to Dr. Lindsay Newman, Director of Economics & Country Risk from IHS Markit on whether this could provide a solution to help end the pandemic.

Image Credit: Shutterstock.com